Along with previous experiments on combined fractionated irradiation and EGFR-TK inhibition, it appears likely that TKI do not affect survival of tumour cells that can cause recurrences but can lead to a good palliative effect by proloning tumour growth for a reasonable amount of time. Here, TKT is linked to neoplasm.